USANA HEALTH SCIENCES INC 8-K

What Happened
USANA Health Sciences, Inc. announced on January 8, 2026 (via an 8‑K) that Jim Brown stepped down as Chief Executive Officer and President. Kevin Guest, age 63, who currently serves as Executive Chairman and previously served as CEO, will reassume the Chief Executive Officer role and will continue as Chairman of the Board. Mr. Brown will remain with the company in an advisory capacity for a period determined by the Board.

Key Details

• Date of filing/announcement: January 8, 2026 (Form 8‑K).
• Leadership change: Jim Brown resigned as CEO/President; Kevin Guest resumes CEO duties while remaining Chairman.
• Advisory role: Mr. Brown will stay on as an advisor at the Board’s discretion.
• Compensation: The Compensation Committee has not yet determined material terms of any separation or compensation arrangements for Mr. Brown; the company will amend the 8‑K to disclose terms once finalized.
• Related-party disclosure: Company stated there are no family or other relationships between Mr. Guest and any director or executive officer requiring Item 404 disclosure.

Why It Matters
A CEO transition is a material leadership change that affects management continuity and may influence company strategy and execution. Investors should note that while leadership succession is clarified (Chairman returning to the CEO role), any financial impact from separation payments or other compensation for Mr. Brown has not yet been disclosed and could affect future reported expenses once finalized. USANA will provide further detail in an amended 8‑K when compensation terms are determined.